Business - Briefly   

US FDA nod for Cadila facility

CHENNAI, JULY 15. Cadila Healthcare Limited has informed the National Stock Exchange that the U.S. Food and Drug Administration (US FDA) which had inspected Zydus Cadila's formulations manufacturing plant has approved the facility. The approval of the manufacturing facility will boost the group's plans and hasten the process of launching its products in the U.S.

Our Bureau

Printer friendly page  
Send this article to Friends by E-Mail

Business

News: Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous |
Advts: Classifieds | Employment | Updates: Breaking News |

Stories in this Section

• Warwick University confers doctorate on Venu Srinivasan
• Impal profit up
• Enron's Chapter 11 plan cleared
• `Estate intended for charity': Birla family
• Textile units need to go upstream, says Vaghela
• Exporters seek dollar credit
• GAIL to set up units in South and East
• Fertilizer units want realistic subsidy
• Exchange rates
• BULLION RATES
• Patni ties up with InteQ
• Elder in pact with Reliance Life
• US FDA nod for Cadila facility
• HP India cuts notebook prices
• TCS issue likely on July 29
• Bank of India ATM
• Assistance for NTC units sought
• Intoto's Chennai centre
• Birlasoft's feat
• Amara Raja to expand PitStop
• Apeejay Surrendra group's new Chairman
• Capital IQ plans further investment
• Nagarjuna Construction gets Rs. 240 cr. order
• Role of IPR
• HMA awards
• Sonata Software bags award
• Godrej Furniture's Noida showroom
• New Vice President for JB Chem
• Aviva's cover for CanFin customers
• Two banks to share ATMs
• BoB hands over dividend cheque
• SMGB loan for solar lighting
• Chicken merchants' plea
• High tech office opened

Copyright © 2004, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu